Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

Reify Health raises $220 million to increase diversity in clinical trial participation

Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D round co-led by Altimeter Capital and...

SK Chemical, ONCOBIX full-scale collaborative research of innovative new drugs

SK Chemicals said it would start joint research on innovative new drugs with Oncobix, a synthetic new drug developer. Under the accord, Oncobix will derive...

BioNTech plans to advance new formulations for mRNA vaccines in new research collaboration

BioNTech SE and Matinas BioPharma, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid...

RedHill reports powerful inhibition of Omicron SARS-CoV-2 variant by the oral drug candidate

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...

Engitix and Takeda expand collaboration in antifibrotic therapy

Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...

Pfizer expands RSV portfolio by acquiring ReViral for up to $525 million

Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...
spot_img

Expert Articles

spot_img